
Combatting fentanyl production and supporting law enforcement action
OTTAWA, ON, March 4, 2025 /CNW/ - Canada is taking significant action to stop the production and devastating impacts of illegal fentanyl and other illegal drugs on public health and public safety. Health Canada plays a critical role in supporting Canadian law and border enforcement in their activities to counter the global drug threat and is taking concrete action to keep communities safe on both sides of the border.
Today, the Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, announced new drug testing labs and a dedicated, full-time team focused on combatting illegal precursor chemicals and drug production. The Federal Government is actioning this by investing $30.7 million to launch a Precursor Chemical Risk Management Unit (PCRMU) and $48 million to establish the Canadian Drug Analysis Centre (CDAC).
The PCMRU will strengthen our ability to support law and border enforcement in stopping the production of illegal drugs and the importation of chemicals used to make them, including through 20 full-time employees.
The CDAC will significantly expand our drug testing lab capacity and analysis capabilities including through new dedicated lab spaces in Toronto and Vancouver. As a result, the new lab could analyze up to 2000 illegal drug samples per year and trace the place and source of production of these samples. Such intelligence will be used by law enforcement and public safety partners to strategically target organized crime. These efforts will be supported by 26 additional full-time employees.
We are working closely with the United States Drug Enforcement Administration to enhance existing collaboration and information sharing between our governments.
These actions will spearhead activities with allies, working collectively to protect communities from the scourge of illegal drugs, like fentanyl.
Quotes
'Fentanyl is a threat to our communities and public safety. We need to do everything we can to strengthen law enforcement's capacity to combat the devastating impact of illegal drugs. The Precursor Chemical Risk Management Unit and the Canadian Drug Analysis Centre are new tools as part of Canada's border plan to support law and border enforcement in detecting and disrupting the illegal fentanyl trade. This is an important step in addressing the overdose crisis and keeping communities safe.'
The Honourable Ya'ara Saks
Minister of Mental Health and Addictions and Associate Minister of Health
'A stronger, tougher, and more comprehensive approach towards precursor chemicals plays a critical role in breaking the supply chains used by criminal networks on both sides of the border. The CDAC and PCRMU, combined with other significant measures that bolster law enforcement capabilities, will help us protect our communities, prevent overdoses, and save lives.'
Kevin Brosseau
Canada's Fentanyl Czar
Quick Facts
Health Canada plays a critical role in supporting Canadian law and border enforcement in their activities to disrupt the global drug threat and is taking concrete action to keep communities safe on both sides of the border.
Canada and the US have one of the closest and most respected relationships in the world and we continue to work together to protect the security of our shared border while facilitating the secure transfer of services and goods.
The PCRMU has already rapidly advanced a number of targeted regulatory actions. This includes a Notice of Intent to enhance oversight of precursor chemicals and drug equipment and increase regulatory flexibility and agility. As well as a Ministerial Order to rapidly schedule three new precursor chemicals (phenethyl bromide, propionic anhydride and benzyl chloride) and the drug, carisoprodol.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
34 minutes ago
- Yahoo
Canadian wildfire smoke impacts Southern Tier air quality
ELMIRA, N.Y. (WETM)— The Southern Tier was under an air quality advisory for 'fine particulate matter' because of the smoke from the wildfires burning in Canada on Saturday, June 7. Doctors are recommending that people stay aware of the effects of unhealthy air conditions in the area. 'Smoke has started to move in because of the Canadian wildfires, and what we have been seeing these days with lots of sunshine and dry conditions, which makes it a lot easier for that smoke to move into our region,' said Alivia Colón, 18 Storm team meteorologist One injured after house fire breaks out in Village of Savona on Sunday There are several ways to determine if air quality is affecting an individual. The impact can occur over time. 'You may hear increased wheezing, moving around becomes a lot more challenging, such as climbing stairs or hills, you may also have other signs of irritation, such as cough, throat irritation, and other allergy-type symptoms,' said Bradley DeWitt, Centralus Health Physician Assistant. Air quality affects everyone, even if it doesn't seem to do so. According to the Department of Ecology, State of Washington, exposure to smoke in the air can make existing heart and lung conditions worse. NYSDEC issues air quality advisory for Southern Tier, Finger Lakes on Saturday & Sunday 'Smoke is smoke, it's not great for anybody's lungs, so I think when the air quality alert is issued, I think in general you should limit your time spent outside,' said Colón. It is especially important for older individuals and people with pre-existing health conditions are more susceptible to stay up to date on air quality. For more information on the air quality in your area, visit Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.


Business Wire
3 hours ago
- Business Wire
Jack Nathan Health Provides Update on Filing of FY 2024–25 Financial Statements and Audit Progress
TORONTO--(BUSINESS WIRE)-- Jack Nathan Medical Corp. (TSXV: "JNH"; OTCQB: "JNHMF"), ("Jack Nathan Health", "JNH" or the "Company") announces that it was unable to file its audited consolidated financial statements, management's discussion and analysis (MD&A), and related CEO and CFO certifications for the fiscal year ended January 31, 2025 (collectively, the 'Annual Filings') by the required deadline of May 31, 2025. The delay was primarily due to the complexity surrounding the Asset Purchase Agreement (APA) completed on December 1, 2024, under which the Company transferred its Canadian medical clinic business and operations to Well Health Technologies Corp. As part of this transaction, access to EMR systems, supporting documents, and clinical records was also transferred, and this has resulted in extended timelines for data retrieval and audit testing. In addition to the operational handover: The Company underwent a change in external auditors during the fiscal year. A significant number of JNH's employees, including finance and administrative staff, transitioned to Well Health. A resulting delay in commencing the audit, which only began in late February 2025 Despite the late start, Jack Nathan Health made every effort to complete the audit by the filing deadline. Based on that intent, the Company did not apply for a Management Cease Trade Order (MCTO) in advance. However, given the ongoing audit, the Company was unable to meet the statutory filing deadline. As a result, the Ontario Securities Commission issued a Failure-to-File Cease Trade Order ('CTO') against the Company on June 6, 2025, under applicable securities legislation. The CTO prohibits trading in the Company's securities in all Canadian jurisdictions where reciprocal orders apply, until the required filings are completed and the order is revoked. The Company continues to work closely with its auditors to finalize the audit and expects to file well within the 90-day period required for automatic revocation of the CTO. 'This past year marked a major transformation for Jack Nathan Health. The transition of our Canadian medical business to Well Health involved an extensive operational and systems handover,' said Mike Marchelletta, CEO of Jack Nathan Health. 'We recognize the delay in our reporting obligations and remain fully committed to transparency. Our team is working diligently to finalize the audit, and we anticipate filing as soon as possible.' About Jack Nathan Medical Corp. Jack Nathan Health ® is a provider of MedSpa services in Canada and a former operator of one of the largest retail medical clinic networks in North America. Established in 2006 the Company expanded its international footprint, delivering exceptional, state-of-the-art, turn-key medical centers in 253 locations globally, with 193 corporately owned and operated. In Canada, the Company grew to 82 locations, including 80 clinics in Walmart locations in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, and Quebec and 2 independent locations, with 22 corporate owned and operated clinics of which 3 included Rehab services and 6 included MedSpa services. In Mexico, the Company grew to 171 corporate owned clinics across Mexico within 3 divisions, including 165 retail clinics, 5 clinics inside Walmart Distribution Centers servicing Walmart Associates, and 1 multidisciplinary clinic. In December 2024, Jack Nathan Health restructured its Canadian medical operations through an asset sale to Well Health Technologies Corp. Following the exit from its Walmart Mexico operations in May 2025, the Company continues to operate its Canadian MedSpa clinics and is actively evaluating strategic opportunities for its future business in Canada, Mexico & USA. For more information, visit or Neither the TSX Venture Exchange nor its Regulation Services Provider (as defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Cautionary Note Concerning Going Concern As previously reported by the Company in its consolidated financial statements and related management's discussion and analysis filed on SEDAR+ ( the Company requires additional financing to enable it to continue operations. In the absence of additional financing in the near term, the Company is not expected to have sufficient funds to meet its obligations. The Company is actively pursuing alternatives to raise the necessary additional financing. There can be no assurances that the Company will be able to secure the necessary financing to enable it to continue as a going concern.
Yahoo
3 hours ago
- Yahoo
Jack Nathan Health Provides Update on Filing of FY 2024–25 Financial Statements and Audit Progress
TORONTO, June 09, 2025--(BUSINESS WIRE)--Jack Nathan Medical Corp. (TSXV: "JNH"; OTCQB: "JNHMF"), ("Jack Nathan Health", "JNH" or the "Company") announces that it was unable to file its audited consolidated financial statements, management's discussion and analysis (MD&A), and related CEO and CFO certifications for the fiscal year ended January 31, 2025 (collectively, the "Annual Filings") by the required deadline of May 31, 2025. The delay was primarily due to the complexity surrounding the Asset Purchase Agreement (APA) completed on December 1, 2024, under which the Company transferred its Canadian medical clinic business and operations to Well Health Technologies Corp. As part of this transaction, access to EMR systems, supporting documents, and clinical records was also transferred, and this has resulted in extended timelines for data retrieval and audit testing. In addition to the operational handover: The Company underwent a change in external auditors during the fiscal year. A significant number of JNH's employees, including finance and administrative staff, transitioned to Well Health. A resulting delay in commencing the audit, which only began in late February 2025 Despite the late start, Jack Nathan Health made every effort to complete the audit by the filing deadline. Based on that intent, the Company did not apply for a Management Cease Trade Order (MCTO) in advance. However, given the ongoing audit, the Company was unable to meet the statutory filing deadline. As a result, the Ontario Securities Commission issued a Failure-to-File Cease Trade Order ("CTO") against the Company on June 6, 2025, under applicable securities legislation. The CTO prohibits trading in the Company's securities in all Canadian jurisdictions where reciprocal orders apply, until the required filings are completed and the order is revoked. The Company continues to work closely with its auditors to finalize the audit and expects to file well within the 90-day period required for automatic revocation of the CTO. "This past year marked a major transformation for Jack Nathan Health. The transition of our Canadian medical business to Well Health involved an extensive operational and systems handover," said Mike Marchelletta, CEO of Jack Nathan Health. "We recognize the delay in our reporting obligations and remain fully committed to transparency. Our team is working diligently to finalize the audit, and we anticipate filing as soon as possible." About Jack Nathan Medical Corp. Jack Nathan Health® is a provider of MedSpa services in Canada and a former operator of one of the largest retail medical clinic networks in North America. Established in 2006 the Company expanded its international footprint, delivering exceptional, state-of-the-art, turn-key medical centers in 253 locations globally, with 193 corporately owned and operated. In Canada, the Company grew to 82 locations, including 80 clinics in Walmart locations in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, and Quebec and 2 independent locations, with 22 corporate owned and operated clinics of which 3 included Rehab services and 6 included MedSpa services. In Mexico, the Company grew to 171 corporate owned clinics across Mexico within 3 divisions, including 165 retail clinics, 5 clinics inside Walmart Distribution Centers servicing Walmart Associates, and 1 multidisciplinary clinic. In December 2024, Jack Nathan Health restructured its Canadian medical operations through an asset sale to Well Health Technologies Corp. Following the exit from its Walmart Mexico operations in May 2025, the Company continues to operate its Canadian MedSpa clinics and is actively evaluating strategic opportunities for its future business in Canada, Mexico & USA. For more information, visit or Neither the TSX Venture Exchange nor its Regulation Services Provider (as defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Cautionary Note Concerning Going Concern As previously reported by the Company in its consolidated financial statements and related management's discussion and analysis filed on SEDAR+ ( the Company requires additional financing to enable it to continue operations. In the absence of additional financing in the near term, the Company is not expected to have sufficient funds to meet its obligations. The Company is actively pursuing alternatives to raise the necessary additional financing. There can be no assurances that the Company will be able to secure the necessary financing to enable it to continue as a going concern. View source version on Contacts Jack Nathan Medical Corp., Mike Marchelletta, Chief Executive Officer; phone: (647) 488-5008 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data